Cargando…
The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study
Postoperative spinal patients remain a challenge for provision of postoperative analgesia. Patient-controlled intravenous analgesia (PCIA) is a major method in reducing the severe pain after the surgery in our institution, but some adverse effects prevent the use of adequate dosage opioids. This stu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265895/ https://www.ncbi.nlm.nih.gov/pubmed/27684802 http://dx.doi.org/10.1097/MD.0000000000004776 |
_version_ | 1782500360271691776 |
---|---|
author | Dong, Chun-Shan Lu, Yao Zhang, Jun Sun, Peng Yu, Jun-Ma Wu, Chao Lu, Qiang |
author_facet | Dong, Chun-Shan Lu, Yao Zhang, Jun Sun, Peng Yu, Jun-Ma Wu, Chao Lu, Qiang |
author_sort | Dong, Chun-Shan |
collection | PubMed |
description | Postoperative spinal patients remain a challenge for provision of postoperative analgesia. Patient-controlled intravenous analgesia (PCIA) is a major method in reducing the severe pain after the surgery in our institution, but some adverse effects prevent the use of adequate dosage opioids. This study was determined using the probit analysis to investigate the optimal dose of dexmedetomidine (DEX) infusion for postoperative analgesia combined with sufentanil (SUF) in spine surgery. The dose of DEX needed to produce satisfactory analgesia conditions following combination of 3.0 μg/kg SUF in PCIA pump, which was diluted to 250 mL with a 4 mL/h as background infusion. Patients were recruited with age 35 to 65 years. The satisfactory criteria of postoperative analgesia were determined with a average satisfaction level of pain control, sedation, self-satisfaction, and adverse effects, among others. The dose of DEX was determined using the modified Dixon's up-and-down method (0.5 μg/kg as a step size). The first patient was test at 3.0 μg/kg DEX. The patient was assessed at 6, 12, 36 hours, and termination of PCIA following the continuous infusion of DEX-SUF mixture in PCIA after surgery. Twenty-five patients were enrolled by predetermined criteria. The optimal dose of DEX required for satisfactory analgesic was 4.33 (SD, 0.38) μg/kg combined with 3.0 μg/kg SUF via a PCIA volume of 250 mL by background infusion of 4 mL/h. Using probit analysis, the ED(50) of DEX was 4.12 μg/kg (95% confidence limits 3.74–4.52 μg/kg) for satisfactory postoperative analgesic in spine surgery, the ED(95) of DEX was 4.85 μg/kg (95% confidence limits 4.48–7.13 μg/kg). There was no report of somnolence or respiratory depression, relevant bradycardia or hypotension, or over sedation in this study. The optimal dose of DEX was 4.33 (0.38) μg/kg(−1) combined with 3.0 μg/kg(−1) SUF diluted to 250 mL with a background infusion of 4 mL/h for satisfactory analgesic after spine surgery. From probit analysis, ED(50) and ED(95) of DEX were 4.12 μg/kg (95% confidence limits 3.74–4.52 μg/kg) and 4.85 μg.kg(−1) (95% confidence limits 4.48–7.13 μg/kg), respectively. |
format | Online Article Text |
id | pubmed-5265895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-52658952017-02-06 The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study Dong, Chun-Shan Lu, Yao Zhang, Jun Sun, Peng Yu, Jun-Ma Wu, Chao Lu, Qiang Medicine (Baltimore) 3300 Postoperative spinal patients remain a challenge for provision of postoperative analgesia. Patient-controlled intravenous analgesia (PCIA) is a major method in reducing the severe pain after the surgery in our institution, but some adverse effects prevent the use of adequate dosage opioids. This study was determined using the probit analysis to investigate the optimal dose of dexmedetomidine (DEX) infusion for postoperative analgesia combined with sufentanil (SUF) in spine surgery. The dose of DEX needed to produce satisfactory analgesia conditions following combination of 3.0 μg/kg SUF in PCIA pump, which was diluted to 250 mL with a 4 mL/h as background infusion. Patients were recruited with age 35 to 65 years. The satisfactory criteria of postoperative analgesia were determined with a average satisfaction level of pain control, sedation, self-satisfaction, and adverse effects, among others. The dose of DEX was determined using the modified Dixon's up-and-down method (0.5 μg/kg as a step size). The first patient was test at 3.0 μg/kg DEX. The patient was assessed at 6, 12, 36 hours, and termination of PCIA following the continuous infusion of DEX-SUF mixture in PCIA after surgery. Twenty-five patients were enrolled by predetermined criteria. The optimal dose of DEX required for satisfactory analgesic was 4.33 (SD, 0.38) μg/kg combined with 3.0 μg/kg SUF via a PCIA volume of 250 mL by background infusion of 4 mL/h. Using probit analysis, the ED(50) of DEX was 4.12 μg/kg (95% confidence limits 3.74–4.52 μg/kg) for satisfactory postoperative analgesic in spine surgery, the ED(95) of DEX was 4.85 μg/kg (95% confidence limits 4.48–7.13 μg/kg). There was no report of somnolence or respiratory depression, relevant bradycardia or hypotension, or over sedation in this study. The optimal dose of DEX was 4.33 (0.38) μg/kg(−1) combined with 3.0 μg/kg(−1) SUF diluted to 250 mL with a background infusion of 4 mL/h for satisfactory analgesic after spine surgery. From probit analysis, ED(50) and ED(95) of DEX were 4.12 μg/kg (95% confidence limits 3.74–4.52 μg/kg) and 4.85 μg.kg(−1) (95% confidence limits 4.48–7.13 μg/kg), respectively. Wolters Kluwer Health 2016-09-30 /pmc/articles/PMC5265895/ /pubmed/27684802 http://dx.doi.org/10.1097/MD.0000000000004776 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 3300 Dong, Chun-Shan Lu, Yao Zhang, Jun Sun, Peng Yu, Jun-Ma Wu, Chao Lu, Qiang The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study |
title | The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study |
title_full | The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study |
title_fullStr | The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study |
title_full_unstemmed | The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study |
title_short | The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study |
title_sort | optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: a probit analysis study |
topic | 3300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265895/ https://www.ncbi.nlm.nih.gov/pubmed/27684802 http://dx.doi.org/10.1097/MD.0000000000004776 |
work_keys_str_mv | AT dongchunshan theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT luyao theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT zhangjun theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT sunpeng theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT yujunma theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT wuchao theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT luqiang theoptimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT dongchunshan optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT luyao optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT zhangjun optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT sunpeng optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT yujunma optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT wuchao optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy AT luqiang optimaldoseofdexmedetomidineaddedtoansufentanilbasedanalgesicregimenforpostoperativepaincontrolinspinesurgeryaprobitanalysisstudy |